Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review
17 févr. 2021 07h30 HE
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the Company”, “Coherus”) announced that the United States Food and Drug Administration (“FDA”) has...
ERIC Releases Groundbreaking Research Showing Significant Savings from Biosimilars
07 avr. 2020 11h14 HE
|
The ERISA Industry Committee
Washington, DC, April 07, 2020 (GLOBE NEWSWIRE) -- The ERISA Industry Committee (ERIC) released groundbreaking research, part of a larger initiative examining the impact of biosimilars on the health...
Ulcerative Colitis Drug Market To Reach USD 10.25 Billion By 2027 | Reports And Data
03 févr. 2020 15h00 HE
|
Reports and Data
New York, Feb. 03, 2020 (GLOBE NEWSWIRE) -- The global ulcerative colitis drug market is forecast to reach USD 10.25 Billion by 2027, according to a new report by Reports and Data. Ulcerative...
Community Oncology Alliance Releases Six New Position Statements
18 sept. 2019 12h50 HE
|
Community Oncology Alliance
Washington, DC, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Community Oncology Alliance (COA) Board of Directors approved six new Position Statements for public release. A unanimous vote at this week’s...
Global Erythropoietin Drugs Market is Expected to Reach USD 18.67 Billion by 2025 : Fior Markets
26 août 2019 08h12 HE
|
Fior Markets
New Jersey, NJ, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Rising prevalence of anaemia caused due to chronic diseases such as cancer, HIV AIDS, chronic kidney disease is driving the global demand for the...
Erythropoietin (EPO) Drugs Market To Cross USD 12 billion by 2020 | Reports And Data
24 juil. 2019 09h51 HE
|
Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Erythropoietin (EPO) Drugs market offers an extensive analysis of the trends to estimate its growth in the near future. It provides...
Global Biosimilars Market Is Estimated to Grow at a CAGR of +6% by 2025 Top Companies are Pfizer, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion
05 juil. 2019 05h50 HE
|
Global Reports Store
PUNE, India, July 05, 2019 (GLOBE NEWSWIRE) -- Global Biosimilars Industry was valued at USD $7.75 Billion in the year 2019. Global Biosimilars Industry is further estimated to grow at a CAGR of...
Biogen to Present New Safety and Efficacy Data on Biosimilars and Estimates 1.8 Billion Euros in Savings for the European Healthcare System in 2019
11 juin 2019 19h05 HE
|
Biogen Inc.
Data to be presented at the European Congress of Rheumatology (EULAR) 2019 highlight real-world evidence confirming the safety and efficacy of anti-TNF biosimilars and high adherence of patients to...
U.S. Non-oncology Biopharmaceuticals Market to Surpass US$ 253.0 Billion by 2026
23 avr. 2019 08h45 HE
|
CMI
SEATTLE, April 23, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. non-oncology biopharmaceuticals market size is estimated to be valued at US$ 116.0 Billion in 2018, and is...
Global Biologics Market Size and Segments
27 mars 2019 11h00 HE
|
The Business Research Company
LONDON, March 27, 2019 (GLOBE NEWSWIRE) -- A report from The Business Research Company shows that the global biologics market size is expected to reach around $319 billion by 2021 at an annual...